Oppenheimer Maintains Outperform on Addus HomeCare, Raises Price Target to $145
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn has maintained an 'Outperform' rating on Addus HomeCare (NASDAQ:ADUS) and raised the price target from $140 to $145.
September 23, 2024 | 1:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer has reaffirmed its 'Outperform' rating for Addus HomeCare and increased the price target to $145, indicating confidence in the company's future performance.
The reaffirmation of the 'Outperform' rating and the increase in the price target from $140 to $145 by Oppenheimer suggests a positive outlook for Addus HomeCare. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100